The U.S. Supreme Court's ruling this week giving drug companies more freedom to use other companies' patented inventions is seen as a victory for large pharmaceutical and biotechnology companies, and cited as one way to speed drug development. The AARP said the ruling would help lower costs for drug development and drug research and that savings would ultimately be passed on to consumers.

Related Summaries